In line with these findings, mice with hepatocyte-specific DPP4 knockdown have shown a significant reduction in DPP4 activity in the serum along with reduced AT inflammation, insulin resistance, and glucose intolerance (305). The gene discussed is DPP4; the disease is Insulin resistance.